Stock ETNB 89BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications 89bio, Inc.

Equities

ETNB

US2825591033

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
8.18 USD -8.40% Intraday chart for 89bio, Inc. -11.09% -26.77%
May. 14 89Bio Initiates Phase 3 Enlighten-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis Patients with Compensated Cirrhosis CI
May. 10 HC Wainwright Adjusts 89bio's Price Target to $29 From $31, Maintains Buy Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. ETNB Stock
  4. News 89bio, Inc.
  5. Official Publications